New Kidney Protein Protects Blood Vessels, Study Finds

University of Colorado School of Medicine

As people age, or as certain diseases progress, their blood vessels can grow stiffer and less resilient. These changes can bring an increased risk of cardiovascular disease and earlier death.

One trigger for blood vessel stiffening is a higher-than-normal level of phosphate in the blood. While elevated blood phosphate (hyperphosphatemia) is not common in the general population, it is much more widespread in people with chronic kidney disease (CKD) because their kidneys lose their effectiveness at filtering out waste products.

Researchers at the University of Colorado Anschutz School of Medicine have discovered a specific protein in the kidneys that plays an important role in balancing blood phosphate levels, and their findings could have especially critical implications for CKD patients.

In a new study published in October 2026, the research team found that having a deficiency of this protein accelerated blood vessel stiffening and shortened life expectancy in animal models, especially when combined with a high phosphate diet. A diet lower in phosphate helped lessen some of these negative effects.

This protein could become a new target for drugs and other treatments aimed at managing phosphate balance in the body. These treatments could be especially beneficial for patients with CKD, helping them live longer and stay in better overall health.

"Phosphate is really underestimated in terms of longevity in all mammals. The higher the concentration of phosphate in the blood, the shorter the lifespan," says Makoto Miyazaki, PhD , a research professor in the Division of Renal Diseases and Hypertension and the senior author of the new study.

How and why the body regulates phosphate levels

Phosphorus is an essential nutrient for bone-building. It's found naturally in many whole foods — ranging from meat, poultry, and fish to whole grains, nuts, legumes, and dairy products — typically in the form of organic phosphate compounds. Processed foods and drinks can also contain phosphate additives to extend shelf life and improve flavor.

The body needs a certain amount of phosphorus to be healthy, but a surplus in the bloodstream (hyperphosphatemia) can set off a cascade of health challenges. Phosphate additives in food may be especially concerning because they absorb faster and more completely into the body than the organic phosphates found in whole foods.

When phosphate levels stay high over time, excess phosphate triggers smooth muscle cells in the blood vessel walls to start acting like bone-forming cells. These cells then begin depositing bone-like calcium phosphate crystals into the vessel walls, which causes them to stiffen (or calcify).

Normally, blood vessels should be supple, expanding and contracting with the body's blood flow needs, but when calcification sets in, it prematurely ages the vessels and can contribute to a range of age-related health problems throughout the body.

The kidneys often filter excess phosphate out of the blood before it causes these problems. But in people with CKD, as the kidneys deteriorate, they become less able to remove phosphate and other substances from the blood.

The body normally manages its phosphate levels through constant adjustments. When the kidneys pull phosphate out of the blood, some of it, but not all, gets flushed out in the urine. A protein called NPT2A reabsorbs about three-quarters of that phosphate back into the bloodstream so the body doesn't lose too much phosphorus at once.

But this reabsorption can become a problem if phosphate levels are running high. Miyazaki and his colleagues found that a different protein, TMEM174, counterbalances NPT2A by binding to it and slowing down the rate of its reabsorbing action.

The new study underscored just how essential TMEM174 is to keeping phosphate levels in check. The researchers found that, in animal models, having a TMEM174 deficiency caused problems with regulating blood phosphate levels, promoted vascular calcification, and significantly shortened lifespan.

"We don't fully understand how yet, but somehow TMEM174 is destabilizing NPT2A," says Miyazaki. "And without enough TMEM174, homeostasis is disrupted."

TMEM174 deficiency appears to be driven mainly by genetics rather than CKD. But the new research suggests that patients with CKD who also don't have sufficient TMEM174 could face compounding health risks.

Possibility for new treatments on the horizon

Miyazaki hopes these findings could open the door to new treatments that help stop the body from reabsorbing excess phosphate from the kidneys.

He says although diet changes could offer modest help — cutting down on phosphate-heavy fast foods, deli meats, sodas, and other processed foods may be especially beneficial — it might be difficult, especially for people with CKD, to manage their phosphates through diet alone. Phosphate is in so many foods that it's nearly impossible to avoid.

In future studies, Miyazaki wants to continue studying these proteins in the kidneys as well as hormones that help maintain chemical balance throughout the body. He also says calcium in blood vessels is very common in people with CKD, and he wants to do further research into why that is.

But in the meantime, unearthing the role of TMEM174 is a concrete step toward better understanding how the body balances its phosphate levels, as well as how people with imbalances can enjoy better health.

"Scientists have been studying phosphate homeostasis for over 100 years, so to still find a new protein that regulates phosphate is kind of unique," says Miyazaki.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.